Recent insights into HIV-1 Vif
- PMID: 15245742
- DOI: 10.1016/j.coi.2004.05.006
Recent insights into HIV-1 Vif
Abstract
The lentiviruses, including HIV-1 (but excluding equine infectious anemia virus), encode a viral infectivity factor (Vif) protein. Circumstantial evidence suggested that Vif acts to neutralize an inhibitory host defense mechanism, but progress in the field was limited because the identity of the cellular target was unknown. The recent identification of the elusive host cell factor let loose a flood of advances. These findings have revealed a novel innate defense mechanism against retroviruses. In infected cells, the cellular cytidine deaminase APOBEC3G, a relative of the activation-induced deaminase (AID), is encapsidated into assembling virions. The enzyme lies in the virion, waiting to wreak havoc on the viral genome in the next round of virus replication--unless it is first caught by Vif.
Similar articles
-
New insights into the role of Vif in HIV-1 replication.AIDS Rev. 2004 Jan-Mar;6(1):34-9. AIDS Rev. 2004. PMID: 15168739 Review.
-
The viral infectivity factor (Vif) of HIV-1 unveiled.Trends Mol Med. 2004 Jun;10(6):291-7. doi: 10.1016/j.molmed.2004.04.008. Trends Mol Med. 2004. PMID: 15177194 Review.
-
A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5652-7. doi: 10.1073/pnas.0400830101. Epub 2004 Mar 30. Proc Natl Acad Sci U S A. 2004. PMID: 15054139 Free PMC article.
-
Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.Cell. 2003 Jul 11;114(1):21-31. doi: 10.1016/s0092-8674(03)00515-4. Cell. 2003. PMID: 12859895
-
HIV-1 Vif versus APOBEC3G: newly appreciated warriors in the ancient battle between virus and host.Trends Microbiol. 2004 Apr;12(4):145-8. doi: 10.1016/j.tim.2004.02.004. Trends Microbiol. 2004. PMID: 15116720 No abstract available.
Cited by
-
Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.Int J Hematol. 2006 Apr;83(3):208-12. doi: 10.1532/IJH97.06013. Int J Hematol. 2006. PMID: 16720549 Review.
-
Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV.Viruses. 2024 Oct 30;16(11):1697. doi: 10.3390/v16111697. Viruses. 2024. PMID: 39599811 Free PMC article. Review.
-
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9854-9. doi: 10.1073/pnas.0501694102. Epub 2005 Jul 6. Proc Natl Acad Sci U S A. 2005. PMID: 16000409 Free PMC article.
-
Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.Cell Microbiol. 2008 Aug;10(8):1662-75. doi: 10.1111/j.1462-5822.2008.01157.x. Epub 2008 Apr 16. Cell Microbiol. 2008. PMID: 18419775 Free PMC article.
-
Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.J Virol. 2013 Feb;87(3):1906-11. doi: 10.1128/JVI.02199-12. Epub 2012 Nov 21. J Virol. 2013. PMID: 23175372 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources